Last reviewed · How we verify
Cholecalciferol 2800 I.U. ml oral drops
Cholecalciferol 2800 I.U. ml oral drops is a Small molecule drug developed by Zagazig University. It is currently in Phase 1 development.
At a glance
| Generic name | Cholecalciferol 2800 I.U. ml oral drops |
|---|---|
| Sponsor | Zagazig University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cholecalciferol 2800 I.U. ml oral drops CI brief — competitive landscape report
- Cholecalciferol 2800 I.U. ml oral drops updates RSS · CI watch RSS
- Zagazig University portfolio CI
Frequently asked questions about Cholecalciferol 2800 I.U. ml oral drops
What is Cholecalciferol 2800 I.U. ml oral drops?
Cholecalciferol 2800 I.U. ml oral drops is a Small molecule drug developed by Zagazig University.
Who makes Cholecalciferol 2800 I.U. ml oral drops?
Cholecalciferol 2800 I.U. ml oral drops is developed by Zagazig University (see full Zagazig University pipeline at /company/zagazig-university).
What development phase is Cholecalciferol 2800 I.U. ml oral drops in?
Cholecalciferol 2800 I.U. ml oral drops is in Phase 1.